Oscar Health (OSCR) Return on Sales (2020 - 2026)

Oscar Health (OSCR) has 7 years of Return on Sales data on file, last reported at 1.19% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 55.0% year-over-year to 1.19%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 1.19%, up from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 1.19% in Q1 2026 and bottomed at 0.16% in Q3 2025.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.09%.
• The widest annual swing landed in 2022, when Return on Sales jumped 296 bps; it then fell 11 bps in 2024.
• A 5-year view of Return on Sales shows it stood at 0.0% in 2022, then jumped by 58 bps to 0.0% in 2023, then jumped by 37 bps to 0.0% in 2024, then soared by 50 bps to 0.0% in 2025, then soared by 393716 bps to 1.19% in 2026.
• The last three Return on Sales figures came in at 1.19% (Q1 2026), 0.0% (Q4 2025), and 0.16% (Q3 2025), per Business Quant data.

Peer Comparison